Patents
Patents for C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
09/2006
09/07/2006DE102005009909A1 Verbindungen geeignet zur Beseitigung fehlgefalteter Proteine Compounds suitable for the removal of misfolded proteins
09/06/2006EP1698629A2 Polyamines and their use in therapy
09/06/2006CN1827733A Organic electroluminescence device
08/2006
08/30/2006EP1373250B1 Viologen linked acridine based molecule and process for the preparation thereof
08/29/2006US7097995 Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes
08/23/2006EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use
08/23/2006CN1271167C Organic electroluminescent element
08/17/2006US20060183905 Derivatives of 4-(thio-or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
08/16/2006EP1689705A2 Fused ring dicationic anti-protozoan agents and their prodrugs
08/16/2006EP1397488B1 Novel compounds for chemiluminescense procedures
08/09/2006EP1687275A1 Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain
08/09/2006EP1177197B1 Polyamines and their use in therapy
08/01/2006US7083986 Acridinium compound for use in the concurrent detection of target analytes in immunoassays or nucleic acid assays
07/2006
07/26/2006EP1532089A4 Fluorene compound and organic luminescent device using the same
06/2006
06/29/2006US20060142323 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
06/27/2006CA2326710C New dihydrofuro-¬3,4-b|quinolein-1-ones derivatives, the procedure for preparing them and the pharmaceutical compositions that contain them
06/22/2006US20060134425 Organic luminescence device (OLED) containing both a 5,5'-spirobi(dibenzosilole) compound and a diarylaminofluorene compound; spiro compounds have improved electron-transporting property, luminescence, and durability
06/14/2006CN1259307C Acylated indanyl amines and their use as pharmaceuticals
06/06/2006US7056912 Heteroaryl derivatives and their use as medicaments
05/2006
05/31/2006EP1660473A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors
05/25/2006US20060111389 Therapeutic acridone and acridine compounds
05/18/2006WO2006051489A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
05/18/2006CA2585983A1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
05/10/2006CN1255365C Fluorene compound and organic lumnescent device using the same
05/03/2006CN1768038A Using alkylmetal reagents for directed metalation of azaaromatics
05/02/2006US7037642 Removing compounds from blood products with porous particles immobilized in a matrix
04/2006
04/25/2006US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease
04/20/2006US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands
04/19/2006CN1252052C Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
04/11/2006US7026310 Heteroaryl derivatives and their use as medicaments
04/11/2006CA2162382C Intercalators having affinity for dna and methods of use
04/04/2006US7022855 Halogen-substituted quinoline derivatives and ectoparasite control agent
04/04/2006CA2235765C Azulenyl nitrone spin trapping agents, methods of making and using same
03/2006
03/30/2006WO2006034036A1 Fluorescent dye compounds, conjugates and uses thereof
03/30/2006CA2581174A1 Fluorescent dye compounds, conjugates and uses thereof
03/29/2006CN1247704C Method for dyeing or printing of fibre materials and three-colour dye mixture
03/23/2006US20060063843 Compounds for the treatment of inflammatory disorders
03/23/2006DE112004000832T5 Lichtemittierende Polymerzusammensetzung Light-emitting polymer composition
03/22/2006CN1751024A Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same
03/14/2006CA1341498C Polysubstituted aryl acridinium esters
03/09/2006US20060051811 Site-specific labelling of proteins using acridone and quinacridone lifetime dyes
03/08/2006EP1353908B1 Processes and synthetic intermediates for preparing n-arylacridancarboxylic acid derivatives
03/08/2006EP0877735B1 Polycyclic compounds
03/08/2006CN1745066A Enzyme substrates, culture media containing same and use thereof in order to detect aminopeptidase activity and/or differentiate gram-positive bacteria from gram-negative bacteria
02/2006
02/23/2006US20060040900 R(-)-10-methoxy-11-O-acetyl-N-n-propyl-noraporphine; Parkinson's disease, sexual dysfunction, and depressive disorders
02/16/2006US20060035306 Used to detect aminopeptidase activity in microorganisms or to determine whether at least one bacterium belongs to the Gram-positive group or to the Gram-negative group according to the color
02/14/2006US6998405 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
02/09/2006US20060030605 Pharmaceutical compounds
02/09/2006US20060030565 Amide derivatives and nociceptin antagonists
02/07/2006US6994980 Chemiluminescent compounds and use thereof
02/02/2006US20060024523 Organic electroluminescence device
02/01/2006CN1239486C Acridine derivative and its application
01/2006
01/26/2006US20060020141 Colorant compounds
01/17/2006US6987120 Pharmaceutical compounds
01/11/2006EP1613322A2 Aminoquinoline compounds
01/10/2006CA2268157C Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives
01/10/2006CA2186618C Novel aryl-n-alkylacridanthiocarboxylate derivatives useful for chemiluminescent detection
01/10/2006CA2184612C Novel aryl n-alkylacridancarboxylate derivatives useful for chemiluminescent detection
01/04/2006EP1611102A2 Using alkylmetal reagents for directed metalation of azaaromatics
01/04/2006EP1169298B1 Pharmaceutical compounds
01/03/2006CA2185350C Acridone-derived bisintercalators as chemotherapeutic agents
12/2005
12/29/2005US20050288522 Process for preparing pentacene derivatives
12/22/2005WO2005121073A1 Inhibitors of histone deacetylase
12/21/2005EP1322670B1 Electrochemiluminescence from acridan compounds
12/13/2005US6974877 Such as 1,4,8,11-tetramethylpentacene by reacting substituted bis(benzyl)phthalic acid with trifluoromethanesulfonic acid
12/07/2005CN1230416C Pharmaceutical compounds
11/2005
11/30/2005EP1098864B9 Method for hydrogenating unsaturated heterocyclic compounds
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1703220A Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
11/24/2005US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger
11/17/2005US20050255528 Amine-reactive quaternary acridinium compounds, e.g., pentafluorophenyloxy-1-carbonyl-4,7,10,13-tetraoxapentadecyl-(15-amino)-3'-sulfonyl-2',6'-dimethylphenyl-N-(3-sulfopropyl)-acridinium-9-carboxylate with increased solubility; chemiluminescent conjugates, especially with antibodies; assay kits
11/16/2005EP0977738B1 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/03/2005US20050245523 Heteroaryl derivatives and their use as medicaments
11/02/2005EP1159261B1 Antizyme modulators and their use
10/2005
10/27/2005WO2004069804A8 Enzyme substrates, culture media containing same and use thereof in order to detect aminopeptidase activity and/or differentiate gram-positive bacteria from gram-negative bacteria
10/27/2005US20050236974 Condensed polycyclic compound and organic light-emitting device using the same
10/26/2005EP1587793A1 Enzyme substrates, culture media containing same and use thereof in order to detect aminopeptidase activity and/or differentiate gram-positive bacteria from gram-negative bacteria
10/20/2005US20050233943 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
10/19/2005EP1019379B1 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein
10/19/2005CN1683338A Process for preparing N-methyl quinoline codide compounds by ester reaction solvent
10/06/2005US20050222167 Amidation of 3-(acidinylamino)-5-methylolanilines with 5-[4-phenylpiperazin-1-yl(thio)carbonylamino]nicotinic acids and the product, which have antitumor activity and low toxicity.
10/06/2005US20050221390 High quantum yield acridinium compounds and their uses in improving assay sensitivity
10/04/2005US6951713 Absorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
10/04/2005CA2146763C Quinolone and acridinone derivatives for the treatment of urinary incontinence
09/2005
09/22/2005US20050209273 Neuroprotectants, analgesics or anticonvulsants
09/14/2005EP1049933B1 Measurement of hydride using chemiluminescent acridinium compounds
09/07/2005EP1539702A4 Hydrophilic chemiluminescent acridinium labeling reagents
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
08/2005
08/30/2005US6936615 Heteroaryl derivatives and their use as medicaments
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/11/2005US20050176744 nitrogen heterocyclyl-(thio)carbonyl- quinoline derivatives used for treating cervical carcinoma or ovarian adenocarcinoma
08/04/2005WO2004091485A3 Aminoquinoline compounds
08/03/2005EP1558255A2 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease
08/02/2005US6924154 Hydrophilic chemilumescent acridinium labeling reagents
07/2005
07/28/2005WO2005051296A3 Fused ring dicationic anti-protozoan agents and their prodrugs
07/28/2005US20050165044 Use against Trypanosoma brucei rhodesiense (T.b.r.) and Plasmodium falciparum; prodrugs of these compounds can be used as oral treatment for malaria and human African trypanosomiasis; 2,7-bis-guanidino-9H-fluorene, 2,7-bis-guanidinofluoren-9-one
07/21/2005WO2005043124A3 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors
07/21/2005US20050158815 High speed signal generation; storage stability
07/20/2005EP1185493B1 Quinones for treatment of diseases
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 22